Amrize Ltd AMRZ
38.22
0.99
2.66%
as of 25 Sep
- Market cap
- $20.5B
- P/E
- 17.5×
Follow AMRZ
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
24.34 | 26.68 | 25.12 | 18.59 |
+6 more quarters Free account |
P/S ratio |
2.42 | 2.60 | 2.53 | 2.16 | |
P/FCF ratio |
21.73 | 22.74 | 20.47 | 18.19 | |
P/Operating CF |
69.95 | (34.59) | 16.58 | 31.77 | |
P/B ratio |
2.29 | 2.37 | 2.28 | 2.08 | |
Price to Tangible BV |
13.81 | 13.39 | 12.73 | 12.53 | |
EV/Sales |
2.85 | 3.02 | 2.82 | 2.56 | |
EV/EBITDA |
12.14 | 12.96 | 11.79 | 10.23 | |
EV/Operating CF |
15.97 | 16.58 | 15.06 | 14.94 | |
EV/FCF |
25.63 | 26.37 | 22.76 | 21.56 | |
Quick Ratio |
0.67 | 0.80 | 1.05 | 0.91 | |
Current Ratio |
1.10 | 1.40 | 1.60 | 1.45 | |
Net Debt/EBITDA |
5.45 | 31.92 | 4.54 | 4.99 | |
Debt/Assets |
24.40% | 24.91% | 21.76% | 24.18% | |
Debt/Equity |
0.47 | 0.46 | 0.40 | 0.45 | |
Asset Turnover |
0.50 | 0.98 | 0.98 | 1.03 | |
Operating CF/Net income |
0.88 | 7.72 | 5.82 | 1.55 | |
Capex/Depreciation |
(0.98) | (1.13) | (0.61) | (0.67) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
8.10% | 13.41% | 10.24% | 8.49% | |
Intangible Assets out of Total Assets |
0.44 | 0.44 | 0.45 | 0.45 | |
Share Based Compensation of Revenue |
0.31% | 0.41% | 0.28% | 0.08% | |
Graham Net Nets |
(0.24) | (0.22) | (0.22) | (0.24) | |
Graham Number |
33.86 | 33.43 | 33.90 | 37.01 | |
Earnings Yield |
4.11% | 3.75% | 3.98% | 5.38% | |
Free Cash Flow Yield |
4.60% | 4.40% | 4.88% | 5.50% | |
Revenue per Share |
6.32 | 3.94 | 5.14 | 6.64 | |
Operating CF per Share |
0.76 | (1.62) | 3.26 | 1.53 | |
Capex per Share |
(0.46) | (0.48) | (0.27) | (0.27) | |
Free Cash Flow per Share |
0.30 | (2.10) | 2.99 | 1.25 | |
Cash per Share |
1.32 | 1.99 | 3.48 | 1.49 | |
Shareholders Equity per Share |
23.27 | 23.66 | 23.72 | 23.32 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
23.27 | 23.66 | 23.72 | 23.32 | |
Free Cash Flow |
168.00 | (1,163.00) | 1,656.00 | 694.00 | |
Working Capital |
430.00 | 1,230.00 | 1,728.00 | 1,417.00 | |
Capital Expenditures |
(253.00) | (267.00) | (148.00) | (151.00) | |
Net Current Asset Value |
(7,161.00) | (6,897.00) | (6,475.00) | (6,568.00) | |
EV/EBIT |
18.30 | 19.51 | 17.45 | 14.38 | |
Capex to Sales |
0.07 | 0.12 | 0.05 | 0.04 | |
Net Profit Margin |
13.68% | (5.33%) | 10.91% | 14.83% | |
Price to Operating Income |
15.52 | 16.82 | 15.69 | 12.13 | |
| Other line items | |||||
Average Receivables |
1,974.50 | 1,479.50 | 1,255.50 | — | |
Average Payables |
1,351.00 | 1,153.00 | 1,389.00 | — | |
Average Inventory |
1,597.00 | 1,509.50 | 1,398.50 | — | |
Average Assets |
24,192.50 | 12,134.50 | 12,104.50 | 12,017.50 | |
Average Common Equity |
12,645.50 | 11,501.00 | 11,162.00 | — |
Columns are period end dates